SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Integrated BioPharma, Inc. INBP OTC

Other OTC • Consumer Defensive • Packaged Foods • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Integrated BioPharma, Inc. (INBP) is a Packaged Foods company in the Consumer Defensive sector, currently trading at $0.28. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Financials: revenue is $54M, -0.9%/yr average growth. Net income is $808,000, growing at +316.7%/yr. Net profit margin is 1.5% (thin). Gross margin is 10.2% (-1.4 pp trend).

Balance sheet: total debt is $1M against $20M equity (Debt-to-Equity (D/E) ratio 0.05, conservative). Current ratio is 4.42 (strong liquidity). Debt-to-assets is 4.1%. Total assets: $25M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 58/100 (Partial), Past 75/100 (Partial), Health 100/100 (Pass), Moat 18/100 (Fail), Future ?/100 (Fail), Income 30/100 (Fail).

INBP SharesGrow Score Overview

64/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 58/100

Financials — average growth

PAST 75/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 18/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 30/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — INBP

INBP trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

INBP: -0.9%/yr revenue is, +316.7%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

INBP: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet INBP: Debt-to-Equity (D/E) ratio 0.05 (conservative), Current ratio is 4.42 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

INBP: Gross margin is 10.2% (-1.4 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 18/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

INBP: Net profit margin is 1.5%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.25-0.42

Volume700

Avg Volume (30D)7.7K

Market Cap$8.7M

Beta (1Y)0.55

Share Statistics

EPS (TTM)0.03

Shares Outstanding$30.3M

IPO Date1996-10-30

Employees147

CEORiva Kay Sheppard

Financial Highlights & Ratios

Revenue (TTM)$54.35M

Gross Profit$5.56M

EBITDA$3.38M

Net Income$808K

Operating Income$2.02M

Total Cash$3.62M

Total Debt$1.02M

Net Debt$-2.6M

Total Assets$24.9M

Price / Earnings (P/E)10.5

Price / Sales (P/S)0.16

Analyst Forecast

Company Info

CountryUS

ExchangeOther OTC

CurrencyUSD

ISINUS45811V1052

Price Chart

INBP

Integrated BioPharma, Inc. ↗ · Other OTC

Consumer Defensive • Packaged Foods

0.25 52WK RANGE 0.42

People Also View

Toyo Suisan Kaisha, Ltd.

Premier Foods plc

Premier Foods plc

TreeHouse Foods, Inc.

Thorne HealthTech, Inc.

Torque Lifestyle Brands, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message